Core Laboratories NV (CLB) - Total Liabilities
Based on the latest financial reports, Core Laboratories NV (CLB) has total liabilities worth $312.58 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Core Laboratories NV - Total Liabilities Trend (1995–2025)
This chart illustrates how Core Laboratories NV's total liabilities have evolved over time, based on quarterly financial data. See Core Laboratories NV working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Core Laboratories NV Competitors by Total Liabilities
The table below lists competitors of Core Laboratories NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LX Semicon Co. Ltd
KQ:108320
|
Korea | ₩357.15 Billion |
|
Dat Xanh Real Estate Service Contructions Corp
VN:DXG
|
Vietnam | ₫17.39 Trillion |
|
Mühlbauer Holding AG
XETRA:MUB
|
Germany | €315.43 Million |
|
Zhejiang Yatai Pharmaceutical Co Ltd
SHE:002370
|
China | CN¥115.18 Million |
|
First Sensor AG
F:SIS
|
Germany | €42.02 Million |
|
Shanghai Yimin Commerce Group Co Ltd
SHG:600824
|
China | CN¥421.99 Million |
|
Shanghai HIUV New Materials Co Ltd
SHG:688680
|
China | CN¥1.48 Billion |
|
Jiangsu United Water Technology Co. Ltd. Cl A
SHG:603291
|
China | CN¥1.99 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Core Laboratories NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CLB market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Core Laboratories NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Core Laboratories NV (1995–2025)
The table below shows the annual total liabilities of Core Laboratories NV from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $317.19 Million | -4.65% |
| 2024-12-31 | $332.67 Million | -6.71% |
| 2023-12-31 | $356.59 Million | -8.43% |
| 2022-12-31 | $389.40 Million | -7.25% |
| 2021-12-31 | $419.85 Million | -14.84% |
| 2020-12-31 | $493.01 Million | -16.80% |
| 2019-12-31 | $592.53 Million | +21.44% |
| 2018-12-31 | $487.93 Million | +11.89% |
| 2017-12-31 | $436.08 Million | +4.39% |
| 2016-12-31 | $417.75 Million | -35.63% |
| 2015-12-31 | $648.96 Million | +11.57% |
| 2014-12-31 | $581.66 Million | +18.31% |
| 2013-12-31 | $491.62 Million | +9.59% |
| 2012-12-31 | $448.60 Million | +5.93% |
| 2011-12-31 | $423.48 Million | +23.21% |
| 2010-12-31 | $343.70 Million | -8.69% |
| 2009-12-31 | $376.41 Million | -0.25% |
| 2008-12-31 | $377.34 Million | -14.47% |
| 2007-12-31 | $441.16 Million | +3.09% |
| 2006-12-31 | $427.93 Million | +138.70% |
| 2005-12-31 | $179.28 Million | -9.19% |
| 2004-12-31 | $197.43 Million | -1.24% |
| 2003-12-31 | $199.92 Million | +22.90% |
| 2002-12-31 | $162.66 Million | -0.26% |
| 2001-12-31 | $163.08 Million | +3.97% |
| 2000-12-31 | $156.86 Million | +3.95% |
| 1999-12-31 | $150.90 Million | +0.27% |
| 1998-12-31 | $150.50 Million | +22.66% |
| 1997-12-31 | $122.70 Million | +282.24% |
| 1996-12-31 | $32.10 Million | +14.23% |
| 1995-12-31 | $28.10 Million | -- |
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more